Efficacy and tolerability of alitretinoin for chronic hand eczema under daily practice conditions: Results of the TOCCATA open study comprising 680 patients

Acta Dermato-Venereologica

Volumn 92, Issue 3, 2012, Pages 251-255

  Diepgen, Thomas L ^a   Pfarr, Egon ^b   Zimmermann, Thomas ^c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b AMS Advanced Medical Services GmbH Mannheim   (Germany)

^c Basilea Pharmaceutica Deutschland GmbH   (Germany)

Author keywords

Alitretinoin; Chronic hand eczema; Observational study: efficacy

Indexed keywords

ALITRETINOIN;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHRONIC HAND ECZEMA; DERMATOLOGIST; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HAND ECZEMA; HEADACHE; HUMAN; HYPERKERATOSIS; LYMPHEDEMA; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; OBSERVATIONAL STUDY; OPEN STUDY; PARANOIA; PRIORITY JOURNAL; SIDE EFFECT; SOFT TISSUE DISEASE; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; CHRONIC DISEASE; ECZEMA; FEMALE; HAND DERMATOSES; HUMANS; KERATOLYTIC AGENTS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TRETINOIN;

EID: 84859778756     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-1256     Document Type: Article

References (24)

1. Coenraads PJ, Nater JP, van der Lende R. Prevalence of eczema and other dermatoses of the hands and arms in the Netherlands. Association with age and occupation. Clin Exp Dermatol 1983; 8: 495-503.
2. Meding B, Jarvholm B. Hand eczema in Swedish adults - changes in prevalence between 1983 and 1996. J Invest Dermatol 2002; 118: 719-723.
3. Fowler JF, Duh MS, Chang J, Person J, Thorn D, Raut M, et al. A survey-based assessment of the prevalence and severity of chronic hand dermatitis in a managed care organization. Cutis 2006; 77: 385-392.
4. Diepgen TL, Agner T, Aberer W, Berth-Jones J, Cambazard F, Elsner P, et al. Management of chronic hand eczema. Contact Dermatitis 2007; 57: 203-210.
5. Hogan DJ, Dannaker CJ, Maibach HI. The prognosis of contact dermatitis. J Am Acad Dermatol 1990; 23: 300-307.
6. Landow K. Hand dermatitis. The perennial scourge. Postgrad Med 1998; 103: 141-142, 145-148, 151-152.
7. Augustin M, Kuessner D, Purwins S, Hieke K, Posthumus J, Diepgen TL. Cost-of-illness of patients with chronic hand eczema in routine care: results from a multi-centre study in Germany. Br J Dermatol 2011; 165: 845-851.
8. Cvetkovski RS, Zachariae R, Jensen H, Olsen J, Johansen JD, Agner T. Quality of life and depression in a population of occupational hand eczema patients. Contact Dermatitis 2006; 54: 106-111.
9. Lynde C, Guenther L, Diepgen TL, Sasseville D, Poulin Y, Gulliver W, et al. Canadian hand dermatitis management guidelines. J Cut Med Surg 2010; 14: 267-284.
10. Halioua B, Richard MA. Mise au point sur l'eczéma chronique des mains. Ann Dermatol Venereol 2010; 137: 315-327.
11. Diepgen TL, Elsner P, Schliemann S, Fartasch M, Kollner A, Skudlik C, et al. Guideline on the management of hand eczema ICD-10 Code: L20. L23. L24. L25. L30. J Dtsch Dermatol Ges 2009; 7 Suppl 3: S1-16.
12. Vena GA, Girolomoni G, De Pità O, Cristaudo A, Pigatto PD, Giannetti A, et al. Linee Guida e raccomandazioni SIDeMaST (Società Italiana Dermatologia). Dermatite cronica eczematosa delle mani (eczema cronico delle mani); Handbook "Italian Society of Dermatology Guidelines - Clinical recommendations". Pisa: Pacini Editore Medicina, First Edition, 2010: p. 71-81.
13. English J, Aldridge R, Gawkrodger DJ, Kownacki S, Statham B, White JM, Williams J. Consensus statement on the management of chronic hand eczema. Clin Exp Dermatol 2009; 34: 761-769.
14. Menne T, Johansen JD, Sommerlund M, Veien NK. Hand eczema guidelines based on the Danish guidelines for the diagnosis and treatment of hand eczema. Contact Dermatitis 2011; 65: 3-12.
15. Dirschka T, Reich K, Bissonnette R, Maares J, Brown T, Diepgen TL. An open-label study assessing the safety and efficacy of alitretinoin in patients with severe chronic hand eczema unresponsive to topical corticosteroids. Clin Exp Dermatol 2011; 36: 149-154.
16. Ruzicka T, Larsen FG, Galewicz D, Horvath A, Coenraads PJ, Thestrup-Pedersen K, et al. Oral alitretinoin (9-cisretinoic acid) therapy for chronic hand dermatitis in patients refractory to standard therapy: results of a randomized, double-blind, placebo-controlled, multicenter trial. Arch Dermatol 2004; 140: 1453-1459.
17. Ruzicka T, Lynde CW, Jemec GB, Diepgen T, Berth-Jones J, Coenraads PJ, et al. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial. Br J Dermatol 2008; 158: 808-817.
18. Toctino Summary of Product Characteristics. 2008. Available from: http://www.medicines.org.uk/emc/medicine/21177/SPC/Toctino+10mg+and+30mg+soft+capsules/.
19. Coenraads PJ, Van Der Walle H, Thestrup-Pedersen K, Ruzicka T, Dreno B, De La Loge C, et al. Construction and validation of a photographic guide for assessing severity of chronic hand dermatitis. Br J Dermatol 2005; 152: 296-301.
20. Coenraads PJ. Hand eczema is common and multifactorial. J Invest Dermatol 2007; 127: 1568-1570.
21. Diepgen TL, Andersen KE, Brandao FM, Bruze M, Bruynzeel DP, Frosch P, et al. Hand eczema classification: a cross-sectional, multicentre study of the aetiology and morphology of hand eczema. Br J Dermatol 2009; 160: 353-358.
22. Bissonnette R, Worm M, Gerlach B, Guenther L, Cambazard F, Ruzicka T, et al. Successful retreatment with alitretinoin in patients with relapsed chronic hand eczema. Br J Dermatol 2009; 162: 420-426.
23. Aguayo-Leiva IR, Urrutia S, Jaen-Olasolo P. Response to treatment with oral alitretinoin in patients with chronic hand eczema that is refractory to treatment with potent topical corticosteroids: Experience in 15 patients. Actas Dermosifiliogr 2011; 102: 616-662.
24. Gånemo A, Sommerlund M, Vahlquist A. Oral alitretinoin in congenital ichthyosis: A pilot study shows variable effects and a risk of hypothyreosis. Acta Derm Venereol 2012; 92: 256-257.